Showing results (851-860 of 1,301) with videos related to

Sort By:
Pageof 131
Respiratory Investigation|May 9, 2024
Squamous metaplasia is an indicator of acute exacerbation in patients with usual interstitial pneumonia / idiopathic pulmonary fibrosisYuri Tachibana, Masatake Hara, Mikiko Hashisako, et al.
Respiratory Investigation|May 26, 2024
Real-world characteristics of patients with asthma initiating fluticasone furoate/umeclidinium/vilanterol single-inhaler triple therapy in JapanToru Oga, Chifuku Mita, Risako Ito, et al.
Respiratory Investigation|May 18, 2024
Antibiotic treatment for patients with exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysisYasuhito Suzuki, Kento Sato, Suguru Sato, et al.
Respiratory Investigation|April 17, 2024
Successful pembrolizumab treatment for microsatellite instability-high thymoma: A case reportTaichi Kaneko, Akimasa Sekine, Shigeru Komatsu, et al.
Respiratory Investigation|April 19, 2024
Abnormal saturated fatty acids and sphingolipids metabolism in asthmaKazufumi Yoshida, Yuko Morishima, Yukio Ishii, et al.
Respiratory Investigation|April 10, 2024
Treatment with systemic corticosteroid versus placebo for exacerbations of COPD: A systematic review and meta-analysisAkira Koarai, Mitsuhiro Yamada, Tomohiro Ichikawa, et al.
Respiratory Investigation|January 24, 2026
Diverse histopathological patterns in Fleischner-defined interstitial lung abnormalities: Radiologic-Pathologic correlation and reclassification using 2025 American Thoracic Society statementTaiki Fukuda, Kaori Ishida, Tomonori Tanaka, et al.
Respiratory Investigation|January 21, 2026
Performance validation of a closed loop fully automated AI model for lung nodule stratification in screening casesA Taha, M S Muneer, A Kalra, et al.
Respiratory Investigation|February 17, 2026
Current perspectives on imaging modalities in the diagnosis and management of pulmonary hypertensionShota Yamamoto, Fumio Sakamaki
Respiratory Investigation|February 11, 2026
Favorable clinical impact of histological subtype with non-small cell carcinoma-not otherwise specified in patients with non-small cell lung cancer receiving immune checkpoint inhibitorsTatsuya Hirano, Ichidai Tanaka, Masahiro Morise, et al.
Pageof 131